Showing results (1-10 of 99) with videos related to
Sort By:
Pageof 10
Biochemistry|January 18, 2006
Membrane topology of human ASBT (SLC10A2) determined by dual label epitope insertion scanning mutagenesis. New evidence for seven transmembrane domainsAntara Banerjee, Peter W SwaanDrug Discovery Today|September 27, 2005
Reengineering the pharmaceutical industry by crash-testing moleculesPeter W Swaan, Sean EkinsEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 9, 2005
Computational approaches to modeling drug transportersCheng Chang, Peter W SwaanDrugs|September 25, 2002
Camptothecins: a review of their chemotherapeutic potentialHulya Ulukan, Peter W SwaanThe Biochemical Journal|February 7, 2014
Resveratrol promotes degradation of the human bile acid transporter ASBT (SLC10A2)Paresh P Chothe, Peter W SwaanMolecular Pharmaceutics|May 8, 2015
Internalization and Subcellular Trafficking of Poly-l-lysine Dendrimers Are Impacted by the Site of Fluorophore ConjugationBrittany R Avaritt, Peter W SwaanAdvanced Drug Delivery Reviews|July 31, 2007
Endocytic mechanisms for targeted drug deliveryLisa M Bareford, Peter W SwaanPharmaceutical Research|March 21, 2014
Intracellular Ca2+ release mediates cationic but not anionic poly(amidoamine) (PAMAM) dendrimer-induced tight junction modulationBrittany R Avaritt, Peter W SwaanBiochemistry|March 4, 2008
Cytosolic half of transmembrane domain IV of the human bile acid transporter hASBT (SLC10A2) forms part of the substrate translocation pathwayChandra M Khantwal, Peter W SwaanMolecular Pharmacology|November 1, 2007
Conformational flexibility of helix VI is essential for substrate permeation of the human apical sodium-dependent bile acid transporterNaissan Hussainzada, Akash Khandewal, Peter W SwaanPageof 10